Propanc Biopharma, Inc. (PPCB) Launches $4 Million IPO on NASDAQ Capital
Propanc Biopharma, Inc. (NASDAQ: PPCB) has officially priced its initial public offering (IPO) at $4.00 per share, raising $4 million through the sale of...
Amanta Healthcare IPO Opens September 1: Key Details and Investor Insights
Amanta Healthcare Limited, a leading pharmaceutical manufacturer, is set to launch its initial public offering (IPO) on September 1, 2025. The book-building issue consists...
NusaTrip Inc. (NUTR) Prices $15 Million IPO on NASDAQ Capital
NusaTrip Inc. (NASDAQ: NUTR), a leading online travel agency (OTA) in Southeast Asia, has officially priced its initial public offering (IPO) at $4.00 per...
Cantor Equity Partners IV, Inc. (CEPF) Launches $400 Million IPO on NASDAQ Global
Cantor Equity Partners IV, Inc. (NASDAQ: CEPF) has officially priced its initial public offering (IPO), raising $400 million through the sale of 40 million...
U.S. IPO Market Booms in 2025 with 222 Listings, Up 86% from Last Year
U.S. IPO Market Surges in 2025 with 222 Listings, Signaling Investor Revival
The U.S. IPO market has witnessed a remarkable surge in 2025, with 222...
